Alopecia in Children Undergoing Chemotherapy, Radiation, and Hematopoietic Stem Cell Transplantation: Scoping Review and Approach to Management
Document Type
Article
Publication Title
Pediatric Dermatology
Abstract
Alopecia is a common sequela in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation. In most cases, this is a transient state in which full hair regrowth eventually occurs, but permanent or persistent alopecia, defined as the presence of incomplete hair regrowth more than 6 months after cessation of treatment, is possible and can be psychologically distressing. We sought to characterize the risk factors that can lead to permanent alopecia following the aforementioned treatments in pediatric populations, as well as diagnostic and treatment options that may be considered, as part of a scoping review of the literature. A general algorithm for approaching these patients was developed based on our findings.
DOI
10.1111/pde.14995
Publication Date
5-2022
Keywords
alopecia, chemotherapy, child, hematopoietic stem cell transplantation, radiation, scalp cooling
ISSN
1525-1470
Recommended Citation
Kessler S, Marzooq A, Sood A, Beebe K, Walsh A, Montoya L, Price H. Alopecia in Children Undergoing Chemotherapy, Radiation, and Hematopoietic Stem Cell Transplantation: Scoping Review and Approach to Management. Pediatric Dermatology. 2022; 39(3). doi: 10.1111/pde.14995.
